II. Indications: Autoimmune Conditions

III. Preparations

  1. Older xTNF agents included Thalidomide
  2. Modern xTNF agents (in 2016) are primarily monoclonal antibodies
    1. Examples include Infliximab (Remicade), Adalimumab (Humira) and Etanercept (Enbrel)

IV. Complications

  1. Nonmelanoma Skin Cancer
  2. Opportunistic Infection or reactivated infections
    1. Tuberculosis
      1. Screen for latent infection prior to initiating TNF agent
    2. Disseminated Histoplasmosis
    3. Coccidioidomycosis
    4. Blastomycosis
    5. Hepatitis B
    6. Cytomegalovirus
    7. Leishmaniasis
  3. References
    1. Toussi (2013) Clin Infect Dis 57:1318–30 +PMID:23899685 [PubMed]

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Ontology: Anti-tumor necrosis factor alpha drug (C1562242)

Concepts Pharmacologic Substance (T121)
SnomedCT 420693002, 416897008
English Anti-tumor necrosis factor alpha agent (substance), Anti-tumor necrosis factor alpha agent, Anti-tumour necrosis factor alpha agent, Anti-TNF drug, Anti-tumor necrosis factor alpha drug (product), Anti-tumor necrosis factor alpha drug, Anti-tumour necrosis factor alpha drug
Spanish agente con anti-factor de necrosis tumoral alfa (sustancia), agente con FNT-alfa, agente con TNF-alfa, agente con anti-factor de necrosis tumoral alfa, factor de necrosis tumoral alfa (producto), factor de necrosis tumoral alfa